https://orcid.org/0000-0003-2396-8260
References
- Hirsch IB, Gaudiani LM. A new look at brittle diabetes. J Diabetes Complications. 2021;35(1):107646. doi:10.1016/j.jdiacomp.2020.107646
- Gill GV, Lucas S, Kent LA. Prevalence and characteristics of brittle diabetes in Britain. QJM. 1996;89(11):839–843. doi:10.1093/qjmed/89.11.839
- Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379. doi:10.1056/NEJMra1600266
- Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi:10.1038/4441022a
- Erejuwa OO, Sulaiman SA, Ab Wahab MS. Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int J Mol Sci. 2014;15(3):4158–4188. doi:10.3390/ijms15034158
- Zhou Z, Sun B, Yu D, Zhu C. Gut microbiota: an important player in type 2 diabetes mellitus. Front Cell Infect Microbiol. 2022;12:834485. doi:10.3389/fcimb.2022.834485
- Li YY, Zhu YX, Zhou Y, Qian C, Zhou Q. Efficacy and safety of washed microbiota transplantation in the treatment of brittle diabetes. Chin J Diabetes Mellitus. 2020;12:962–967.
- Liu X. Practical Endocrinology. People’s Medical Officer Press; 1997:356.
- Zhigu L, Bin Y, Beisi L, et al. Correlation between glycemic variability indices calculated by self-monitoring of blood glucose and mean amplitude of glycemicexcursion in patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus. 2021;13(5):476–481.
- Lebovitz HE, Banerji MA. Ketosis-prone diabetes (flatbush diabetes): an emerging worldwide clinically important entity. Curr Diab Rep. 2018;18(11):120. doi:10.1007/s11892-018-1075-4
- Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–1359. doi:10.1126/science.1124234
- Chen B, Wang Z, Wang J, et al. The oral microbiome profile and biomarker in Chinese type 2 diabetes mellitus patients. Endocrine. 2020;68(3):564–572. doi:10.1007/s12020-020-02269-6
- Sato J, Kanazawa A, Ikeda F, et al. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care. 2014;37(8):2343–2350. doi:10.2337/dc13-2817
- Medina-Vera I, Sanchez-Tapia M, Noriega-López L, et al. A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes. Diabetes Metab. 2019;45(2):122–131. doi:10.1016/j.diabet.2018.09.004
- Sedighi M, Razavi S, Navab-Moghadam F, et al. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog. 2017;111:362–369. doi:10.1016/j.micpath.2017.08.038
- Brown CT, Davis-Richardson AG, Giongo A, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011;6(10):e25792. doi:10.1371/journal.pone.0025792
- Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, et al. Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study. Diabetes Care. 2018;41(11):2385–2395. doi:10.2337/dc18-0253
- Péan N, Le Lay A, Brial F, et al. Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto-Kakizaki rats improves glucose homeostasis through enhanced FXR signalling. Diabetologia. 2020;63(6):1223–1235. doi:10.1007/s00125-020-05122-7
- Le Bourgot C, Ferret-Bernard S, Apper E, et al. Perinatal short-chain fructooligosaccharides program intestinal microbiota and improve enteroinsular axis function and inflammatory status in high-fat diet-fed adult pigs. FASEB J. 2019;33(1):301–313. doi:10.1096/fj.201800108R
- De Vadder F, Kovatcheva-Datchary P, Zitoun C, Duchampt A, Bäckhed F, Mithieux G. Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metab. 2016;24(1):151–157. doi:10.1016/j.cmet.2016.06.013